发明名称 |
Methods of Treatment of Retinal Degeneration Diseases |
摘要 |
The methods comprise administering cells having properties of stem cells or progenitor cells, to the retina and reprogramming of retinal cells mediated by cell fusion of said cells with said retinal cells, said reprogramming being mediated by activation of the Wnt/β-catenin signalling pathway. |
申请公布号 |
US2014199277(A1) |
申请公布日期 |
2014.07.17 |
申请号 |
US201214237297 |
申请日期 |
2012.08.06 |
申请人 |
Cosma Maria Pia;Sanges Daniela |
发明人 |
Cosma Maria Pia;Sanges Daniela |
分类号 |
A61K35/28;A61K31/506 |
主分类号 |
A61K35/28 |
代理机构 |
|
代理人 |
|
主权项 |
1. A cell selected from the group consisting of a hematopoietic stem cell (HSC), a progenitor cell, and a mesenchymal stem cell (MSC), wherein the Wnt/β-catenin signalling pathway of said cell is activated, for use in the treatment of a retinal degeneration disease. |
地址 |
Barcelona ES |